Analyst Reco. Bio-Rad Laboratories, Inc.

Equities

BIO

US0905722072

Real-time Estimate Cboe BZX Other stock markets 20:24:41 30/04/2024 BST			5-day change	1st Jan Change
270.5 ^USD	-2.37%		-4.80%	-15.89%

04-29	RBC Capital Adjusts Price Target on Bio-Rad Laboratories to $420 From $474	MT
04-26	Bio-Rad Laboratories, Inc. Announces Executive Vice President and President Changes, Life Science Group	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RBC Capital Adjusts Price Target on Bio-Rad Laboratories to $420 From $474	04-29	MT
Zacks Investment Research Lowers Price Target on Bio-Rad Laboratories to $285 From $322	04-15	MT
RBC Trims Price Target on Bio-Rad Laboratories to $474 From $480, Keeps Outperform Rating	04-08	MT
Citigroup Downgrades Bio-Rad Laboratories to Neutral From Buy, Adjusts Price Target to $365 From $400	04-03	MT
UBS Adjusts Bio-Rad Laboratories Price Target to $420 From $395, Maintains Buy Rating	02-16	MT
RBC Trims Price Target on Bio-Rad Laboratories to $480 From $484, Keeps Outperform Rating	02-16	MT
Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom...	01-03
UBS Initiates Coverage on Bio-Rad Laboratories With Buy Rating, $395 Price Target	12-07	MT
RBC Cuts Price Target on Bio-Rad Laboratories to $482 From $513, Notes 'Near-Term Headwinds,' Keeps Outperform Rating	27/10/23	MT
ANALYST RECOMMENDATIONS : Amazon, Comcast, Intel, Merck, Roblox...	27/10/23
Wells Fargo Adjusts Price Target on Bio-Rad Laboratories to $525 From $550, Keeps Overweight Rating	07/08/23	MT
Wells Fargo Lowers Price Target on Bio-Rad Laboratories to $525 From $550, Maintains Overweight Rating	07/08/23	MT
Credit Suisse Adjusts Bio-Rad Laboratories' Price Target to $550 From $580, Keeps Outperform Rating	04/08/23	MT
RBC Raises Price Target on Bio-Rad Laboratories to $524 From $522, Maintains Outperform Rating	04/08/23	MT
RBC Cuts Bio-Rad Laboratories' Price Target to $522 From $536, Keeps Outperform Rating	17/07/23	MT
Wells Fargo Initiates Bio-Rad Laboratories With Overweight Rating, $550 Price Target	16/06/23	MT
ANALYST RECOMMENDATIONS : Adobe, Wells Fargo, American Express...	16/06/23
RBC Boosts Price Target on Bio-Rad Laboratories to $536 From $531, Maintains Outperform Rating	15/05/23	MT
Citigroup Adjusts Bio-Rad Laboratories' Price Target to $525 From $550, Keeps Buy Rating	08/05/23	MT
RBC Cuts Price Target on Bio-Rad Laboratories to $531 From $582 After Guidance Cut But Sees Buying Opportunity After Stock Drop; Outperform Kept	08/05/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Bio-Rad Laboratories, Inc.

Equities

BIO

US0905722072

Analyst Reco.

Filters